Genetic Associations with Valvular Calcification and Aortic Stenosis
By G. Thanassoulis, Catherine Y. Campbell, David S Owens, J. G. Smith, Albert V. Smith, G. Peloso, Kathleen F. Kerr, S. Pechlivanis, M. Budoff, T. Harris and 29 more. New England Journal of Medicine, 2013
904 citations recorded by the source corpus.
BACKGROUND Limited information is available regarding genetic contributions to valvular calcification, which is an important precursor of clinical valve disease. METHODS We determined genomewide associations with the presence of aorticvalve calcification (among 6942 participants) and mitral annular calcification (among 3795 participants), as detected by computed tomographic (CT) scanning; the study population for this analysis included persons of white European ancestry from three cohorts participating in the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (discovery population). Findings were replicated in independent cohorts of persons with either CT-detected valvular calcification or clinical aortic stenosis. RESULTS One SNP in the lipoprotein(a) (LPA) locus (rs10455872) reached genomewide significance for the presence of aorticvalve calcification (odds ratio per allele, 2.05; P = 9.0×10−10), a finding that was replicated in additional white European, African-American, and Hispanic-American cohorts (P<0.05 for all comparisons). Genetically determined Lp(a) levels, as predicted by LPA genotype, were also associated with aorticvalve calcification, supporting a causal role for Lp(a). In prospective analyses, LPA genotype was associated with incident aortic stenosis (hazard ratio per allele, 1.68; 95% confidence interval [CI], 1.32 to 2.15) and aortic-valve replacement (hazard ratio, 1.54; 95% CI, 1.05 to 2.27) in a large Swedish cohort; the association with incident aortic stenosis was also replicated in an independent Danish cohort. Two SNPs (rs17659543 and rs13415097) near the proinflammatory gene IL1F9 achieved genomewide significance for mitral annular calcification (P = 1.5×10−8 and P = 1.8×10−8, respectively), but the findings were not replicated consistently. CONCLUSIONS Genetic variation in the LPA locus, mediated by Lp(a) levels, is associated with aorticvalve calcification across multiple ethnic groups and with incident clinical aortic stenosis. (Funded by the National Heart, Lung, and Blood Institute and others.)
Subfields: Cardiology and Cardiovascular Medicine, Nephrology, Surgery
View Paper: https://www.semanticscholar.org/paper/8fa16dec7c0eba2ddd64ba69048249a02fdc16fc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Surgery
- Børge G. Nordestgaard
- Jan Boren
- A. Tybjærg-Hansen
- M. Chapman
- Marja-Riitta Taskinen
- Alberico L. Catapano
- N. Rifai
- I. Graham
Citations in the corpus
- Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Med (2016, background): “, for myocardial infarction and aortic valve stenosis (11, 46, 47)”
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease (2013, background): “Imaging techniques are also useful in detecting aortic valve calcification and stenosis, which is particularly relevant in homozygous FH and in individuals with elevated Lp(a) levels.(34)”